Sandoz Group AG

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Public

Established: 1986-01-01

Employees: 20K

Market Cap: $19B

Website: http://www.sandoz.com

Clinical Trials

To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Imipramine Hydrochloride 50 mg Tablets (Sandoz Inc.)
Drug: Tofranil Imipramine Hydrochloride 50 mg Tablets (Tyco Healthcare)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 48

Registration Number: NCT00946764

To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers

Phase 1

Completed

Conditions: Psychosis

Interventions: Drug: Haloperidol 10 mg Tablets (Cord Laboratories)
Drug: Haldol 10 mg Tablets (McNeil Pharmaceuticals)

First Posted Date: 2009-07-27

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 30

Registration Number: NCT00946491

Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair

Phase 2

Completed

Conditions: Asthma

First Posted Date: 2009-06-25

Last Posted Date: 2017-03-29

Lead Sponsor: Sandoz

Target Recruit Count: 105

Registration Number: NCT00927758

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
CompleWare, Iowa City, Iowa, United States
🇺🇸
University of Wisconsin, Madison, Wisconsin, United States

To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions
Drug: Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions
Drug: Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 18

Registration Number: NCT00913952

To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Norpramin 50 mg Tablets Merrell Dow Pharmaceuticals, Inc
Drug: Desipramine HCl 50 mg Tablets Cord Laboratories

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00914004

To Demonstrate the Relative Bioavailability of Atenolol Tablets

Phase 1

Completed

Conditions: Hypertension

Interventions: Drug: Atenolol Tablets 100 mg (Cord Laboratories)
Drug: Atenolol Tablets 100 mg (Stuart Pharmaceutical)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 24

Registration Number: NCT00913965

To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Desipramine HCL 100 mg Tablets Cord Laboratories
Drug: Norpramin 100 mg Tablets Merrell Dow Pharmaceuticals, Inc

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00913809

To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Norpramin 100 mg Tablets (Merrell Dow Pharmaceuticals, Inc.)
Drug: Desipramine Hydrochloride 100 mg Tablets (Cord Laboratories)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00913822

To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Epilepsy
Bipolar Disorder

Interventions: Drug: Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA)
Drug: Depakote 500 mg DR Tablets (Abbott Laboratories, USA)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 30

Registration Number: NCT00913874

To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets

Phase 1

Completed

Conditions: Allergy

Interventions: Drug: Clemastine Fumarate Tablets, 2.68 mg (Cord Laboratories)
Drug: Tavist Tablets, 2.68 mg (Sandoz Pharmaceutical Corp.)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00913549

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy